Year: 2020

Éragny-sur-Oise, France, le 24 décembre 2020 à 8h30 CET – Safe Orthopaedics (FR0013467123 – ALSAF), société spécialisée dans la conception, la fabrication et commercialisation de technologies prêtes-à-l’emploi pour la chirurgie du dos, particulièrement sécurisantes pour les fractures vertébrales traitées en urgence, annonce la mise en œuvre de la ligne de financement obligataire flexible annoncée le 17 décembre 2020, se décomposant en 24 tranches dégressives d’OCEANE et souscrite auprès du fonds Luxembourgeois European High Growth Opportunities Securitization Fund (l’« Investisseur »), par l’émission de 1.680 bons d’émission d’obligations convertibles ou échangeables en actions nouvelles et/ou existantes d’une valeur nominale de 5.000 € chacune (les « OCEANE »), décidée par le Président-Directeur Général le 23 décembre, le tirage de...

TORONTO, Dec. 23, 2020 (GLOBE NEWSWIRE) — McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) is deeply saddened to announce the passing of our dear friend and Director of 15 years, Dr. Leanne Baker.“I will miss Leanne’s clear and wise counsel, her warm friendship and courage. After her dear family, mining was one of her big passions and the industry has lost a valued champion!” stated Rob McEwen, Chairman & Chief Owner.“Leanne was a special person – fearless, embodying strength of conviction and humanity while always sharing her experience and acumen so generously. I admired her greatly and wanted to share her last words to me: Never give up,” remembers Carmen Diges, General Counsel.“Very sad, a reminder of the loss of loved ones and that time is precious. Leanne was a trailblazer and an inspiration to all women in mining who follow...

NEW YORK, Dec. 23, 2020 (GLOBE NEWSWIRE) — Staffing 360 Solutions, Inc. (NASDAQ: STAF), a staffing company executing an international buy-integrate-build strategy through the acquisition of staffing organizations in the United States and the United Kingdom, today announced that it has priced its previously announced underwritten public offering of 4,188,405 shares of its common stock at a public offering price of $0.60 per share, for aggregate gross proceeds of approximately $2.5 million. In addition, Staffing 360 Solutions has granted the underwriter a 30-day option to purchase up to an additional 628,260 shares of common stock at the public offering price, less the underwriting discounts and commissions. The offering is expected to close on or about December 29, 2020, subject to customary closing conditions.The Company intends...

VANCOUVER, British Columbia, Dec. 23, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company announces that the Company has elected to exercise its acceleration right under the warrant indenture (the “Indenture”) governing the common share purchase warrants of the Company (the “November Warrants”) issued on November 1, 2019, Pursuant to the terms of the Indenture, the Company may accelerate the expiry date of the November Warrants when the daily volume-weighted average trading price (the “VWAP”) of the common shares of the Company (the “Common Shares”) exceeds $0.35 for the preceding 20 consecutive trading days on the Canadian Securities Exchange (the “CSE”).As of the close of markets on December 11, 2020,...

MALVERN, Pa., Dec. 23, 2020 (GLOBE NEWSWIRE) — Ocugen, Inc., (NASDAQ: OCGN), a leading biopharmaceutical company focused on discovering, developing and commercializing a pipeline of innovative therapies, today announced the appointment of a vaccine scientific advisory board comprised of leading academic and industry experts in the vaccine field to evaluate the clinical and regulatory path to approval in the US market of Bharat Biotech’s COVAXIN™, a whole-virion inactivated COVID-19 vaccine candidate to be co-developed by Ocugen and Bharat Biotech for the US market.Dr. Shankar Musunuri, Chairman, CEO, and Co-Founder of Ocugen remarked, “We are thrilled to welcome this group of esteemed thought leaders to the Ocugen team to assist in our co-development with Bharat Biotech of COVAXIN™. This unique yet traditional vaccine candidate...

SASKATOON, Saskatchewan, Dec. 23, 2020 (GLOBE NEWSWIRE) — GESPEG RESOURCES LTD. (TSX-V:GCR) (the “Company” or “Gespeg”), is pleased to announce the closing of a non-brokered private placement (the “Offering“) for total gross proceeds of $548,549.92. The closing consists of 900,000 Non-Flow through Units (the “Units”) at a price of $0.08 per Unit and 4,332,272 flow-through common share in the capital of the Company (a “FT Share”) at a price of 0.11 per FT Share. Each Unit consists of one common share in the capital of the Company (a “Share”) and one half of a common share purchase warrant for the purchase of one additional Share at a price of $0.12 for a period of two years from the closing of the Offering.In connection with the closing of the Offering, the Company paid an aggregate finders’ fees of $30,336.00 in...

VANCOUVER, British Columbia, Dec. 23, 2020 (GLOBE NEWSWIRE) — Sandfire Resources America Inc. (TSX.V: “SFR”; OTCQB: “SRAFF”) (“Sandfire America” or the “Company”) is pleased to announce that it has closed its previously announced rights offering, issuing 200,539,763 common shares of the Company for gross proceeds of $30,080,965 (the “Rights Offering“), representing 100% of the total rights offered.The Company’s largest shareholder, Sandfire BC Holdings Inc. (“Sandfire BC”), fully exercised its basic subscription privilege to purchase its pro rata share of the common shares offered, being 170,869,433 common shares, and also purchased an additional 17,739,705 common shares through the exercise of its additional subscription privilege, for a total subscription of 188,609,138...

CELEBRATION, Fla., Dec. 23, 2020 (GLOBE NEWSWIRE) — KemPharm, Inc. (OTCQB: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced that the Company’s Board of Directors has approved a 1-for-16 reverse stock split of its shares of common stock (“Reverse Stock Split”). KemPharm’s stockholders granted authority to the Board of Directors to effect this Reverse Stock Split of KemPharm’s common stock at the Special Meeting of Stockholders held on November 17, 2020. The Reverse Stock Split is intended to enable the Company to potentially regain its listing on the Nasdaq Capital Market.The Reverse Stock Split is scheduled to take effect today, December 23, 2020, at 5:01 p.m. ET (the “Effective Time”). Shares of the Company’s common stock will be assigned a new CUSIP...

NEW YORK, Dec. 23, 2020 (GLOBE NEWSWIRE) — Harvest Capital Credit Corporation (NASDAQ: HCAP) (“HCAP”) and Portman Ridge Finance Corporation (NASDAQ: PTMN) (the “Company” or “PTMN”) announced today that they have entered into a definitive agreement under which HCAP will merge with and into PTMN, a business development company managed by Sierra Crest Investment Management LLC (“Sierra Crest”), an affiliate of BC Partners Advisors L.P. (“BC Partners”).The transaction has been approved by a unanimous vote of Special Committee of the Board of Directors of HCAP, the Board of Directors of HCAP (other than directors affiliated with HCAP’s external investment adviser who abstained from voting) and the Board of Directors of PTMN. In addition, the Board of Directors of HCAP will recommend that HCAP stockholders vote in favor of adoption and...